*
Eikon search string for individual stock moves: STXBZ
*
The Day Ahead newsletter: https://refini.tv/3LI4BU7
*
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street's main indexes were set to open lower on Thursday as fresh data
underscored strength in the U.S. economy and aggravated concerns over the
Federal Reserve's continued policy tightening. .N
At 8:47 a.m. ET, Dow e-minis 1YMc1 were down 0.62% at 33,362. S&P 500
e-minis ESc1 were down 0.79% at 3,875, while Nasdaq 100 e-minis NQc1 were
down 1.10% at 11,210.25.
The top three NYSE percentage gainers premarket .PRPG.NQ :
** The Goldman Sachs Group Inc GS , up 11.5%
** Team Inc TISI.K , up 9.6%
** New York City REIT Inc NYC , up 9.4%
The top two NYSE percentage losers premarket .PRPL.NQ :
** AMC Entertainment Holdings Inc AMC , down 24%
** CarMax Inc KMX , down 14.6%
** Micron Technology Inc MU.O : down 4.5% premarket
Falls after wider-than-expected Q2 loss forecast urn:newsml:reuters.com:*:nL4N33B37R
** Under Armour Inc UAA.N : down 1.5% premarket
Under Armour appoints CEO; shares down urn:newsml:reuters.com:*:nL4N33B3BU
** ORIC Pharmaceuticals Inc ORIC.O : up 55.0% premarket
Jumps on Pfizer partnership, investment urn:newsml:reuters.com:*:nL4N33B3FH
** Nvidia Corp NVDA.O : down 2.2% premarket
** Qualcomm Inc QCOM.O : down 1.8% premarket
** Texas Instruments Inc TXN.O : down 1.0% premarket
** Advanced Micro Devices Inc AMD.O : down 1.8% premarket
** Intel Corp INTC.O : down 1.0% premarket
** Broadcom Inc AVGO.O : down 1.7% premarket
Chip stocks down as Micron flags persisting inventory pressure urn:newsml:reuters.com:*:nL4N33C1WE
** ProQR Therapeutics N.V PRQR.O : up 58.2% premarket
Surges on expanded collaboration with Lilly urn:newsml:reuters.com:*:nL4N33C220
** IsoPlexis Corp ISO.O : up 34.8% premarket
Soars on buyout deal with Berkeley Lights urn:newsml:reuters.com:*:nL4N33C22C
** CarMax Inc KMX.N : down 14.6% premarket
Falls on pausing share buyback as quarterly profit plunges 86% urn:newsml:reuters.com:*:nL4N33C256
** Alvotech SA ALVO.O : up 18.7% premarket
Up as FDA to decide on approval for Humira's biosimilar in April urn:newsml:reuters.com:*:nL4N33C24U
** Mirati Therapeutics Inc MRTX.O : up 6.0% premarket
Gains on FDA's 'breakthrough therapy' tag for colon cancer treatment
urn:newsml:reuters.com:*:nL4N33C26O
(Compiled by Mariam E Sunny)
((Mariam.ESunny@thomsonreuters.com))